Masimo Corporation
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Masimo Corporation sits in the top decile of US sponsors by registered trial count (#245 of 15,742 sponsors by registered trial count).
Masimo Corporation: 96 sponsored US clinical trials, 3 recruiting.
Masimo Corporation sponsors 96 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 80 completed. The most-studied condition in this pipeline is Healthy, with 12 trials.
Top-decile sponsor footprint
Masimo Corporation ranks in the top decile of sponsors by registered trial count (#245 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
80 of 93 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
96 total, page 1 of 2
Philips FAST SpO2 Technology With Masimo Sensors for SpO2 Monitoring in the Neonatal, Infant, and Pediatric Populations
NCT07223177
Validation of the Masimo Irregular Heartbeat Detection Algorithm in Participants Without Cardiovascular Disease
NCT07223164
Investigation of Skin Pigmentation Effect on Performance of Masimo Pulse Oximetry (INSPIRE)
NCT06432881
Validation Study of Mean Arterial Pressure (MAP) Parameter of Masimo INVSENSOR00073
NCT06334055
Clinical Performance Testing of Philips FAST SpO2 With Masimo Pulse Oximetry Sensors Across Skin Pigmentation
NCT06148623
Clinical Validation for SpO2 Function of Masimo INVSENSOR00069
NCT06120777
Performance Comparison Between Masimo W1™ and Apple Watch Series 8
NCT05968079
Validation of the Performance of the Electrocardiogram (ECG) Function in the Masimo INVSENSOR00057
NCT06071754
Impact of Bridge™ Device to Treat Opioid Withdrawal Symptoms
NCT05924945
SpO2 Data Collection in Pediatric Patients Using INVSENSOR00061
NCT05896267
Form, Fit, and Function of INVSENSOR00061
NCT05926648
Validation of the Masimo INVSENSOR00063 in Febrile and Afebrile Subejcts
NCT05787782
Clinical Performance of Masimo Rad-GT
NCT05779397
Calibration and Validation of the Masimo Temperature Device in Febrile Patients
NCT05674344
Clinical Equivalence of Masimo INVSENSOR00061 to RD SET Neo
NCT05674136
Repeatability and Reproducibility of Oxygen Reserve Index (ORi)
NCT05636098
Clinical Performance of Masimo INVSENSOR00057 for Atrial Fibrillation Detection
NCT05476250
Performance of Masimo INVSENSOR00057 in Detecting Atrial Fibrillation (Afib)
NCT05472012
Clinical Performance of Masimo INVSENSOR00057 for Heart Rate Measurements
NCT05462886
Feasibility of Bridge for Post-Operative Pain Management in Hip Arthroplasty
NCT05017701
Clinical Performance of Masimo INVSENSOR00040
NCT05332392
Performance of Masimo MightySat Pulse Oximeter in Differing Levels of Skin Pigmentation
NCT05083351
Convenience Sample Data Collection for INVSENSOR00045
NCT04894669
Effect of Skin Pigmentation and Race/Ethnicity Factors on the Accuracy of Masimo Pulse Oximeters
NCT04889222
Validation of Noninvasive Blood Pressure Device
NCT04676152
Noninvasive Hemoglobin Repeatability and Reproducibility in a Blood Donation Setting
NCT04490863
Noninvasive Hemoglobin Testing, Prospective Blood Donors
NCT04450381
INVSENSOR00027 Fall Detection Clinical Performance Study
NCT04224753
Rad-67 Repeatability and Reproducibility
NCT04196907
Desaturation Validation of INVSENSOR00039
NCT04112784
Oxygen Reserve Index (ORi) Expanded Data Set Validation of INVSENSOR00029
NCT04079842
Oxygen Reserve Index (ORi) Expanded Data Set Validation of INVSENSOR00025
NCT04079816
Desaturation Validation of INVSENSOR00038
NCT04017611
Desaturation Validation of INVSENSOR00037
NCT04002973
Desaturation Validation of INVSENSOR00036
NCT04002960
INVSENSOR00032 and INVSENSOR00033 Respiration Rate Clinical Performance Study
NCT03897179
Feasibility and Performance Evaluation of INVSENSOR00024
NCT03831282
Comparison of Depth of Sedation Performance Between SedLine and Comparator Device During General Anesthesia
NCT03865316
Performance Comparison of Masimo O3 Regional Oximetry Sensors in Neonates
NCT03828487
Desaturation Validation of INVSENSOR00031
NCT03783780
Desaturation Validation of INVSENSOR00028
NCT03704636
Validation of RPVi as a Parameter to Predict Fluid Responsiveness
NCT03706430
Hemodilution Validation of INVSENSOR00026
NCT03677375
Oxygen Reserve Index (ORi) Validation of INVSENSOR00029
NCT03678103
INVSENSOR00027 Clinical Performance Study
NCT03650192
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation of INVSENSOR00026
NCT03610269
Correlation of Changes in PaO2 and ORi in Adult Patients
NCT03488238
Oxygen Reserve Index (ORi) Validation of INVSENSOR00025
NCT03628898
INVSENSOR00011 Clinical Performance Study
NCT03641937
Feasibility and Performance Evaluation for INVSENSOR00024
NCT03570255
Therapeutic Areas
What is open in the Masimo Corporation pipeline
3 recruiting of 96 indexed (3% open); 80 completed (83%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Healthy (12 trials), 7 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Masimo Corporation: open-pipeline peers nationwide
Peers matched on 96 registered trials and 3% open enrollment, not the therapeutic-area sidebar.
Masimo Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 96 trials (± recruiting share)
- University of Mississippi Medical Center · 96 trials · 10% recruiting
- University of Tennessee · 96 trials · 13% recruiting
- Arkansas Children's Hospital Research Institute · 97 trials · 19% recruiting
- AdventHealth · 95 trials · 17% recruiting
Sponsors near 3% open enrollment (± trial volume)
- Allina Health System · 3% recruiting · 32 trials
- CooperVision · 3% recruiting · 64 trials
- MiMedx Group · 3% recruiting · 32 trials
- Sharp HealthCare · 3% recruiting · 32 trials
Related
What to do with this Masimo Corporation page
96 registered trials is a research-attention snapshot, not an endorsement of Masimo Corporation or any single study.
- 3 of Masimo Corporation's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition Masimo Corporation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Masimo Corporation pipeline card: 96 registered trials from official public datasets.Report a data error.